The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from keeping production in the US to localize the supply chain and ensure the speed of delivery. The pressures on companies change as a product nears the end of the life cycle, when the process is well established and the goal is to make it cheaply and efficiently in large volumes without compromising on quality. Piramal Pharma Solutions is a rare example of a CDMO that can support biopharma companies as their products move through the life cycle.
